| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.6B | $30.6B | $28.3B | $26.3B | $6.8B | $6.3B | $6.2B | — |
| Cost of Revenue | $11.3B | $21.3B | $19.4B | $18.6B | $17.7B | $16.6B | $15.9B | — |
| Gross Profit | $1.9B | $9.3B | $8.9B | $7.7B | $2.2B | $2.0B | $1.9B | $2.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.8B | $9.1B | — | $5.9B | $5.9B | $5.5B | $7.9B | $5.0B |
| Operating Income | $1.5B | $-0.9B | $2.2B | $1.8B | $0.7B | $0.2B | $-2.1B | $0.8B |
| Net Income | $-3.7B | $-1.0B | $1.6B | $1.3B | $0.5B | $0.1B | $-2.3B | $1.0B |
| EPS (Basic) | $-17.18 | $-4.55 | $7.24 | $5.83 | $5.68 | $3.49 | $-6.69 | $7.24 |
| EPS (Diluted) | $-17.17 | $-4.55 | $7.21 | $5.80 | $2.13 | $0.52 | $-9.66 | $4.37 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.6B | $22.0B | $23.0B | $21.7B | $20.7B | $19.6B | $13.5B | $16.3B |
| Current Assets | $9.1B | $6.1B | $6.4B | $5.6B | $5.1B | $4.3B | $4.3B | $4.6B |
| Cash & Equivalents | $1.3B | $0.7B | $0.6B | $1.0B | $1.4B | $0.5B | $0.4B | $1.1B |
| Total Liabilities | $14.7B | $14.7B | $14.3B | $14.0B | $13.4B | $13.3B | $7.9B | $9.2B |
| Current Liabilities | $8.6B | $4.7B | $4.2B | $4.2B | $3.7B | $3.5B | $2.1B | $2.9B |
| Stockholders' Equity | $4.0B | $7.3B | $8.8B | $7.7B | $7.3B | $6.3B | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $2.7B | $1.6B | $1.4B | $2.7B | $1.9B | $1.8B | $1.5B |
| Investing Cash Flow | — | $-2.1B | $-1.3B | $-1.0B | $-0.9B | $-1.0B | $-0.8B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | $0.8B | $0.6B |
| Financing Cash Flow | $-0.4B | $-0.5B | $-0.7B | $-0.8B | $-0.9B | $-0.7B | $-1.6B | $-0.7B |